This article looked at the impact of nerve-sparing (NS) surgery on positive surgical margin (PSM) location and the recurrence of tumors in patients following radical prostatectomy (RP; prostate removal surgery). The authors found that having NS surgery on both sides of the prostate increased the risk of PSM and was associated with a higher rate of tumor recurrence. 

This study examined the use of paclitaxel (Taxol) and carboplatin (Paraplatin) as weekly chemotherapy (CT) with trastuzumab (Herceptin) and pertuzumab (Perjeta) in HER2+ breast cancer (BC) in order to reduce toxicity rates. The authors found that the weekly regimen of chemotherapy can be considered an alternative to standard chemotherapy regimens for HER2+ BC. 

This study looked at the use of olaparib (Lynparza) treatment for patients with high risk, BRCA1/2-positive, HER2-negative breast cancer (BC). The authors found that in patients with BRCA1/2-positive BC, olaparib after local treatment improved the outcomes of these patients.

This study looked at the effects of dulaglutide (Trulicity) on erectile function in men with type 2 diabetes (T2D). It found that men with T2D taking dulaglutide were less likely to develop erectile dysfunction (ED) than those taking a placebo.

This study evaluated whether liraglutide (Victoza) improves diabetic control in patients with difficult to control type 2 diabetes (T2D) and if there were certain factors that influence the effects of liraglutide. It found that patients responded equally well to liraglutide regardless of body mass index (BMI; a measurement of weight in relation to height), diabetes duration, and other factors.

This study looked at how beta-blockers affected patients following a heart attack. It found that patients using a low dose of beta-blockers had better outcomes one year later.

This study looked at the use of piperazine ferulate (PF) in diabetic patients. It found that adding PF to angiotensin receptor blocker (ARB) treatment helped to protect kidney function in patients with diabetes.

This study looked at the use of blood pressure (BP)-lowering medications in patients with normal to high blood pressure and its effect in preventing major cardiovascular events (MACE). It found that lowering BP led to a reduction in the risk of heart attack, stroke, or death in all patients, regardless of their pre-treatment BP level.

This study evaluated the safety and effectiveness of dual chimeric antigen receptor (CAR) T-cell therapy for patients with recurrent or hard-to-treat B-cell non-Hodgkin lymphoma (NHL). This study found that this treatment was safe and effective for these patients.

This study evaluated whether antiplatelet therapy after percutaneous coronary intervention (PCI) should be given personalized for each patient. It found that guided therapy resulted in a reduction in the overall risk of heart attack, stroke, and death compared to standard therapy.